Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Unknown 3Terminated 3Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 2NET 1Endocrine 1Breast 1

Conditions

NSCLC 2Carcinoma, Non-Small-Cell Lung 2Lung Neoplasms 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Liquid Biopsy × Thoracic × Clear all
NCT07432308 2026-03-06

Liquid biopsy

Institute of Oncology Ljubljana

Phase NA Completed
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05462795 2024-12-16

Liquid Biopsy for Early Non-small Lung Cancer Detection

University of Arizona

Completed
171 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02890849 2024-02-23

RadImm01

Xinqiao Hospital of Chongqing

Phase NA Completed
60 enrolled
Thoracic

NSCLC

NCT03073902 2018-12-28

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Xinqiao Hospital of Chongqing

Completed
80 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡